Cargando…

Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey

BACKGROUND: Adherence to medications improves glycaemic control and reduces diabetes-related morbidity and mortality. OBJECTIVES: The study assessed drug therapy for type 2 diabetes, glycaemic control and association of medication adherence with socio-demographic and clinical data, among adult diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Eze, Uchenna I.H., Akhumi, Tolulope F., Iheanacho, Chinonyerem O., Saka, Sule A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667283/
https://www.ncbi.nlm.nih.gov/pubmed/36406057
http://dx.doi.org/10.1016/j.rcsop.2022.100200
_version_ 1784831692161155072
author Eze, Uchenna I.H.
Akhumi, Tolulope F.
Iheanacho, Chinonyerem O.
Saka, Sule A.
author_facet Eze, Uchenna I.H.
Akhumi, Tolulope F.
Iheanacho, Chinonyerem O.
Saka, Sule A.
author_sort Eze, Uchenna I.H.
collection PubMed
description BACKGROUND: Adherence to medications improves glycaemic control and reduces diabetes-related morbidity and mortality. OBJECTIVES: The study assessed drug therapy for type 2 diabetes, glycaemic control and association of medication adherence with socio-demographic and clinical data, among adult diabetic patients attending a healthcare facility. METHODS: Cross-sectional survey and hospital records were used to obtain data. The study included 200 adults with type 2 diabetes mellitus in a Nigerian healthcare facility. Data on patients clinical characteristics, diabetes drug therapy and medication adherence were collected, entered and anlaysed using SPSS version 24 (P <0.05). Primary outcome measure was medication adherence among the patients, while secondary outcome measures was glycaemic control. RESULTS: A total of 200 (100%) respondents participated in the study and the majority 141(70.5%) were over 60 years old. Oral medications were mostly used 187(93.5%), particularly, metformin 199(99.5%) and pioglitazone 100(50.0%), while dipeptidyl peptidase-4 inhibitors were not used at all. Patients mostly had poor glycaemic control 159 (79.5%) and majority 152(76.0%) did not practice self-blood glucose monitoring. Moderate medication adherence was predominant in the population. Class of medicine and socio-demographics were not significantly associated with medication adherence (P>0.05), unlike results of blood glucose self-tests (p=0.001). CONCLUSION: Oral antidiabetics, particularly metformin and pioglitazone were mostly used. Poor glycaemic control and moderate adherence were found in the patients, and medication adherence was associated with self-glucose monitoring. This emphasises the need for regular diabetes education on medication adherence.
format Online
Article
Text
id pubmed-9667283
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96672832022-11-17 Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey Eze, Uchenna I.H. Akhumi, Tolulope F. Iheanacho, Chinonyerem O. Saka, Sule A. Explor Res Clin Soc Pharm Article BACKGROUND: Adherence to medications improves glycaemic control and reduces diabetes-related morbidity and mortality. OBJECTIVES: The study assessed drug therapy for type 2 diabetes, glycaemic control and association of medication adherence with socio-demographic and clinical data, among adult diabetic patients attending a healthcare facility. METHODS: Cross-sectional survey and hospital records were used to obtain data. The study included 200 adults with type 2 diabetes mellitus in a Nigerian healthcare facility. Data on patients clinical characteristics, diabetes drug therapy and medication adherence were collected, entered and anlaysed using SPSS version 24 (P <0.05). Primary outcome measure was medication adherence among the patients, while secondary outcome measures was glycaemic control. RESULTS: A total of 200 (100%) respondents participated in the study and the majority 141(70.5%) were over 60 years old. Oral medications were mostly used 187(93.5%), particularly, metformin 199(99.5%) and pioglitazone 100(50.0%), while dipeptidyl peptidase-4 inhibitors were not used at all. Patients mostly had poor glycaemic control 159 (79.5%) and majority 152(76.0%) did not practice self-blood glucose monitoring. Moderate medication adherence was predominant in the population. Class of medicine and socio-demographics were not significantly associated with medication adherence (P>0.05), unlike results of blood glucose self-tests (p=0.001). CONCLUSION: Oral antidiabetics, particularly metformin and pioglitazone were mostly used. Poor glycaemic control and moderate adherence were found in the patients, and medication adherence was associated with self-glucose monitoring. This emphasises the need for regular diabetes education on medication adherence. Elsevier 2022-11-04 /pmc/articles/PMC9667283/ /pubmed/36406057 http://dx.doi.org/10.1016/j.rcsop.2022.100200 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Eze, Uchenna I.H.
Akhumi, Tolulope F.
Iheanacho, Chinonyerem O.
Saka, Sule A.
Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
title Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
title_full Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
title_fullStr Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
title_full_unstemmed Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
title_short Drug therapy and medication adherence in type 2 diabetes in a care facility: A cross sectional survey
title_sort drug therapy and medication adherence in type 2 diabetes in a care facility: a cross sectional survey
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667283/
https://www.ncbi.nlm.nih.gov/pubmed/36406057
http://dx.doi.org/10.1016/j.rcsop.2022.100200
work_keys_str_mv AT ezeuchennaih drugtherapyandmedicationadherenceintype2diabetesinacarefacilityacrosssectionalsurvey
AT akhumitolulopef drugtherapyandmedicationadherenceintype2diabetesinacarefacilityacrosssectionalsurvey
AT iheanachochinonyeremo drugtherapyandmedicationadherenceintype2diabetesinacarefacilityacrosssectionalsurvey
AT sakasulea drugtherapyandmedicationadherenceintype2diabetesinacarefacilityacrosssectionalsurvey